CAS: 568-02-5; Alizarine Blue

结构式图片

MSDS等安全信息

    上下游产品

    3-氨基-1,2-二羟基蒽-9,10-二酮 3-Amino-1,2-Dihydroxyanthraquinone 3963-78-8
    媒介橙 14 3-Nitroalizarin 568-93-4

    合成工艺路线路线简述

      📜Naphtho[2,3-F]Quinoline-5,6,7,12-Tetraone,Alkaline Earth Salt Of/the/ Methylsulfuric Acid 反应生成 5-羟基-4H-萘并[2,3-F]喹啉-6,7,12-三酮
      参考文献:De171836
      标题:De171836

      海关参考信息

      专利信息


      专利号:US-3983145-A
      优先权日:1973-11-01
      标 题:Use of alpha-di(lower alkoxy) anthraquinones in the synthesis of Alizarin Saphirols
      发明人:WHITE DAVID L; FITZPATRICK JOSEPH W
      权利人:TOMS RIVER CHEMICAL CORP
      摘要:Alpha-dihydroxyanthraquinones used as intermediates in the synthesis of many dyestuffs, such as the Alizarin Saphirols (e.g. Color Constitution No. 63000, 63005, 63010, 63011, 63315 and 63610) can be replaced on an equimolar basis by alpha-di(lower alkoxy)anthraquinones. The alpha-di(lower alkoxy) anthraquinones can be converted in a single step, by treatment with oleum, to the corresponding alpha-dihydroxyanthraquinone-beta-disulfonic acids in almost quantitative yield. The corresponding diamine is obtained by dinitrating followed by reduction of the nitro groups. The known intermediate, leuco 1,4,5,8-tetrahydroxyanthraquinone (see C.I. No. 62500) can be obtained either by reduction of the diamine or by reduction of the dinitro compound. In one embodiment, the alpha-di(lower alkoxy)anthraquinone is obtained from dinitroanthraquinone by treatment thereof with methanol and KOH.

      专利号:US-5786341-A
      优先权日:1993-03-26
      标题:Use of a COL1A1 mini-gene construct to inhibit collagen synthesis
      发明人:PROCKOP DARWIN J; KHILLAN JASPAL; LI SHI-WU; PEREIRA RUTH
      权利人:UNIV JEFFERSON
      摘要:Methods are provided for controlling the synthesis of protein from the human gene for the pro alpha 1(I) chain of type I procollagen in cells using mini-gene constructs which are injected into cells which synthesize the protein. Methods for controlling collagen deposition in tissue mini-gene constructs are also provided.

      专利号:US-2023097824-A1
      优先权日:2020-05-08
      标 题:Semi-synthesis and use of racemic hematoxylin
      发明人:DURRANT EDWARD E; HEINDL DIETER; HUBER FLORIAN MAURITIUS ERASUMU; KLEIN ERIC; KOSMEDER II JEROME W; VOSS EDGAR
      权利人:VENTANA MED SYST INC; ROCHE DIAGNOSTICS OPERATIONS INC
      摘要:A racemic hematoxylin formulation is disclosed that includes one or both of a stabilizer compound and an antioxidant. The disclosed composition exhibits sufficient stability to be utilized in an automated staining process. Methods of using and making the stabilized composition also are disclosed.

      专利号:TW-201204250-A
      优先权日:2010-04-13
      标题:Method for the synthesis of substituted pyrrolines

      专利号:WO-9422487-A1
      优先权日:1993-03-26
      标 题 :Use of a col 1a1 mini-gene construct to inhibit collagen synthesis

      专利号:CN-115612114-A
      优先权日:2021-07-14
      标 题:Method and application of copolymer film and its enzymatic self-assembly synthesis

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知